Patents by Inventor Derek Mortisen

Derek Mortisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9750852
    Abstract: Bioabsorbable polymer scaffolds with coatings are disclosed that include immobilized antithrombotic agents on the scaffolds or in or on the coatings. The agents act synergistically with antiproliferative agents released from coatings by providing hemocompatibility during and without interfering with antiproliferative agent release. Methods of modifying scaffolds and coatings with the antithrombotic agents are disclosed.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: September 5, 2017
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Derek Mortisen, Yunbing Wang
  • Patent number: 9669137
    Abstract: It is provided herein modified polylactide (PLA) polymers comprising biocompatibile functional group(s) on the polymers and methods of making and using the modified PLA polymers.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: June 6, 2017
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Stephen Pacetti, Fuh-Wei Tang, Xiao Ma, Ni Ding, Derek Mortisen
  • Publication number: 20160296676
    Abstract: Bioabsorbable polymer scaffolds with coatings are disclosed that include immobilized antithrombotic agents on the scaffolds or in or on the coatings. The agents act synergistically with antiproliferative agents released from coatings by providing hemocompatibility during and without interfering with antiproliferative agent release. Methods of modifying scaffolds and coatings with the antithrombotic agents are disclosed.
    Type: Application
    Filed: June 21, 2016
    Publication date: October 13, 2016
    Inventors: Derek Mortisen, Yunbing Wang
  • Patent number: 9446172
    Abstract: Bioabsorbable polymer scaffolds with coatings are disclosed that include immobilized antithrombotic agents on the scaffolds or in or on the coatings. The agents act synergistically with antiproliferative agents released from coatings by providing hemocompatibility during and without interfering with antiproliferative agent release. Methods of modifying scaffolds and coatings with the antithrombotic agents are disclosed.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 20, 2016
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Derek Mortisen, Yunbing Wang
  • Publication number: 20150217028
    Abstract: It is provided herein modified polylactide (PLA) polymers comprising biocompatibile functional group(s) on the polymers and methods of making and using the modified PLA polymers.
    Type: Application
    Filed: February 3, 2015
    Publication date: August 6, 2015
    Inventors: Stephen Pacetti, Fuh-Wei Tang, Xiao Ma, Ni Ding, Derek Mortisen
  • Publication number: 20150128527
    Abstract: Methods of stabilizing the molecular weight of polymer stents scaffolds after E-beam sterilization are disclosed. The molecular weight of the polymer of the irradiated scaffolds is stabilized through exposure to gas containing oxygen.
    Type: Application
    Filed: January 14, 2015
    Publication date: May 14, 2015
    Inventors: Yunbing Wang, Derek Mortisen, Xiao Ma, Fuh-Wei Tang, Byron Lambert
  • Patent number: 8966868
    Abstract: Methods of stabilizing the molecular weight of polymer stents scaffolds after E-beam sterilization are disclosed. The molecular weight of the polymer of the irradiated scaffolds is stabilized through exposure to gas containing oxygen.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: March 3, 2015
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, Derek Mortisen, Xiao Ma, Fuh-Wei Tang, Byron Lambert
  • Publication number: 20140336747
    Abstract: Implants for treating insufficient blood flow to a heart muscle with transmyocardial revascularization are disclosed. Methods of treating insufficient blood flow to a heart muscle with the implant are also disclosed. The implant can have a body with an inner lumen that supports a channel in the heart muscle to allow for increased blood flow through the lumen upon implantation. The implant can include active agents to prevent or inhibit thrombotic closure of the channel, to promote vascularization, or both.
    Type: Application
    Filed: April 15, 2014
    Publication date: November 13, 2014
    Inventors: Richard Rapoza, Nadine Ding, Yunbing Wang, Stephen Pacetti, Derek Mortisen
  • Publication number: 20120290075
    Abstract: Bioabsorbable polymer scaffolds with coatings are disclosed that include immobilized antithrombotic agents on the scaffolds or in or on the coatings. The agents act synergistically with antiproliferative agents released from coatings by providing hemocompatibility during and without interfering with antiproliferative agent release. Methods of modifying scaffolds and coatings with the antithrombotic agents are disclosed.
    Type: Application
    Filed: May 10, 2011
    Publication date: November 15, 2012
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: DEREK MORTISEN, YUNBING WANG
  • Publication number: 20120285123
    Abstract: Methods of stabilizing the molecular weight of polymer stents scaffolds after E-beam sterilization are disclosed. The molecular weight of the polymer of the irradiated scaffolds is stabilized through exposure to gas containing oxygen.
    Type: Application
    Filed: May 9, 2011
    Publication date: November 15, 2012
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, Derek Mortisen, Xiao Ma, Fuh-Wei Tang, Byron Lambert